HR4525Referred to Committee
Right to FDA-Approved Medicines Act
Introduced
In Committee
3
Passed One Chamber4
Passed Both5
Signed into Law119th
Congress
2025-07-17
Introduced
29
Cosponsors
HR
ⓘType
Sponsor
Deborah K. Ross
Democrat · NC · Representative
Votes with party: 99.0% (606 recorded votes)
Top industries funding sponsor:
- Progressive Groups$78k
- Climate & Environment$1k
Full profile: /officials/R000305
Source: Congress.gov · FEC
Cosponsors (29)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
- Kathy Castor (D-FL-14)Original· 2025-07-17
- Kim Schrier (D-WA-8)Original· 2025-07-17
- Lizzie Fletcher (D-TX-7)Original· 2025-07-17
- Lori Trahan (D-MA-3)Original· 2025-07-17
- Bonnie Watson Coleman (D-NJ-12)· 2025-07-21
- Jennifer L. McClellan (D-VA-4)· 2025-07-29
- Nikema Williams (D-GA-5)· 2025-07-29
- Steve Cohen (D-TN-9)· 2025-07-29
- Marilyn Strickland (D-WA-10)· 2025-08-05
- Mary Gay Scanlon (D-PA-5)· 2025-08-12
- Suzan K. DelBene (D-WA-1)· 2025-08-12
- Yvette D. Clarke (D-NY-9)· 2025-08-12
- Timothy M. Kennedy (D-NY-26)· 2026-01-20
- Veronica Escobar (D-TX-16)· 2026-01-20
- Joyce Beatty (D-OH-3)· 2026-01-21
- Sarah Elfreth (D-MD-3)· 2026-01-21
- Dina Titus (D-NV-1)· 2026-01-22
- Grace Meng (D-NY-6)· 2026-01-22
- Marc A. Veasey (D-TX-33)· 2026-01-30
- Scott H. Peters (D-CA-50)· 2026-01-30
- Ted Lieu (D-CA-36)· 2026-01-30
- Julie Johnson (D-TX-32)· 2026-02-11
- Lois Frankel (D-FL-22)· 2026-02-11
- Jahana Hayes (D-CT-5)· 2026-03-19
- Mark DeSaulnier (D-CA-10)· 2026-03-19
- April McClain Delaney (D-MD-6)· 2026-04-27
- Angie Craig (D-MN-2)· 2026-04-30
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Committee Activity
Currently in
- House Committee on Energy and CommerceReferred To · 2025-07-17
Previously
- Energy and Commerce CommitteeReferred To · 2025-07-17
Plain-English Summary
This bill would allow patients to access medications that the FDA has approved in other countries but not yet approved in the United States, even if those drugs haven't completed the full U.S. approval process. The legislation aims to give terminally ill or seriously ill patients more options when standard treatments aren't working, though it would likely include some safeguards to ensure the drugs meet basic safety standards. The change would affect patients with life-threatening conditions, pharmaceutical companies, and the FDA's drug approval process.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Subjects
Health
Full bill text is not yet cached locally.
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- HRES1410Congratulating the Carolina Hurricanes on winning the 2026 Stanley Cup Championship, the team's first Stanley Cup win in 20 years.Referred to Committee · 2026-06-30
- HR9481RETURN ActReferred to Committee · 2026-06-25
- HR9333AI Flaw Reporting and Security Enhancement ActReferred to Committee · 2026-06-25
- HR9253Protect Working Musicians Act of 2026Referred to Committee · 2026-06-10